Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Michael Anthonavage, VP of innovation at Vitaquest International, about the company’s 2027 consumer trends forecast and how it’s shaping supplement formulation.
|Articles|August 10, 2011
Blood Pressure, Circulation Supplement to Enter Clinical Trial
Dietary supplements brand Nathans Natural announced that its Levodyn supplement will begin a Phase II clinical trial.
Advertisement
Dietary supplements brand Nathans Natural announced that its Levodyn supplement will begin a Phase II clinical trial to study its safety and efficacy in lowering blood pressure and improving blood circulation in mildly hypertensive subjects.
The company says that the trial will be a double-blind, randomized, placebo-controlled, parallel-group, multicenter study. It will be performed by contract research organization Vedic Lifesciences (Redwood Shores, CA).
Advertisement
Related to this article
The policy is a drug-compounding framework, not a supplement pathway, but it changes the regulatory backdrop for peptide products, drug preclusion arguments, and gray-market competition.
Live from SupplySide Global 2026, Laurentia Bliss talks about new athlete-focused research on Magtein, ThreoTech’s brain-targeted magnesium ingredient, and upcoming innovations like effervescent tablets and gummies.
Session speakers at SupplySide Global 2026 covered consumer survey data, extraction methods, dosing, and claims for formulators working with functional mushrooms in beverages and foods.
Panelists at SupplySide Global 2026 discussed protein's limits, shifting supplement formats, clean-label expectations, and plainer ingredient communication.
Live from SupplySide Global 2026, Klaus Neumann talks about Concordix's chewable supplement line spanning beauty and gut-immune health, including BeautyBioti, a Skin & Hair Vitality Complex, and FortiBiotic.
Live from SupplySide Global 2026, Nutritional Outlook’s Nicholas Jacobus speaks with Mit Metah, executive vice president at Unibar, about the launch of ElaQuin and how it connects to Bellaneo, Unibar’s melanin-inhibiting cosmeceutical ingredient.
At SupplySide Global 2026, Jordi Riera of Kaneka Probiotics describes the company’s focus on research and probiotics for women’s health.
Advertisement
Advertisement
Trending on Nutritional Outlook - Supplement, Food & Beverage Manufacturing Trends
1
What the Interim Compounding Pathway for Peptides Could Mean for Supplement Brands
2
Formulating With Functional Mushrooms: What Extraction and Dose Mean for Beverages and Foods
3
Vitaquest's 2027 Consumer Trends Forecast
4
SupplySide Global Panel Weighs Purpose, Transparency, and Affordability in Nutrition
5